Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6562322 | 0.82 | PIK3CD (0.40) | MEN1KMT2AALDH1A1KDM4EHSD17B10 | |
| SCHEMBL80295 | 0.69 | — | — | |
| SCHEMBL21605368 | 0.67 | PIK3CD (0.35) | KDM4E | |
| SCHEMBL27799991 | 0.65 | — | — | |
| SCHEMBL12470124 | 0.64 | SMN1; SMN2 (0.43) | MEN1KMT2AALDH1A1KDM4EHSD17B10 | |
| SCHEMBL24135057 | 0.64 | GAA (0.33) | ALDH1A1 | |
| SCHEMBL20632595 | 0.64 | — | — | |
| SCHEMBL28273402 | 0.64 | — | — | |
| SCHEMBL12423960 | 0.64 | — | — | |
| Propane SCHEMBL27802993 | 0.63 | MEN1 (0.48) | MEN1KMT2AALDH1A1HSD17B10PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105772086-A | (S)-1-(1-hydroxyethyl-1-isopropyl) thiourea modified Mn-Anderson type heteropoly acid catalyst, and preparation method and application thereof | 上海应用技术学院 | 2016-07-20 | — | — | CN | disclosed |
| CN-105772086-A | (S)-1-(1-hydroxyethyl-1-isopropyl) thiourea modified Mn-Anderson type heteropoly acid catalyst, and preparation method and application thereof | 上海应用技术学院 | 2016-07-20 | — | — | CN | disclosed |
| CN-101501031-B | Oxazolidone derivatives as PR modulators | WYETH (US) | 2012-02-01 | — | — | CN | disclosed |
| US-7618990-B2 | 4-[2-(4,4-Dimethyl-2-thioxo-1,3-oxazolidin-3-yl)-1,3-thiazol-4-yl]benzonitrile; progesterone receptor (PR); contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, hormone replacement therapy | WYETH (US) | 2009-11-17 | — | — | US | disclosed |
| EP-2054410-A2 | OXAZOLIDONE DERIVATIVES AS PR MODULATORS | Wyeth (US) | 2009-05-06 | — | — | EP | disclosed |
| US-20080045556-A1 | Oxazolidone derivatives as PR modulators | WYETH (US) | 2008-02-21 | — | — | US | disclosed |
| WO-2008021331-A2 | OXAZOLIDONE DERIVATIVES AS PR MODULATORS | WYETH (US) | 2008-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080045556-A1 | Oxazolidone derivatives as PR modulators | MC2R, NPY1R, PRLHR | MEN1 699/4885KMT2A 667/4885ALDH1A1 3334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.